- About Us
- Advertise
- Contact Us
- CureToday.com
- CancerNetwork.com
- OncLive.com
- OncNursingNews.com
- Do Not Sell My Information
- Privacy
- Terms & Conditions
© 2022 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Allegheny Health Network | Association Partnerships
At Allegheny Health Network (AHN), compassion and innovation meet. We bring together groundbreaking procedures, advanced technology, and the latest research to create new models of care that provide exceptional health care.
To refer a patient call 844-MD-REFER
Connect with us:
Latest from Allegheny Health Network
AHN Partners With Illumina to Assess Role of Comprehensive Genomic Profiling
May 26, 2022
Article
Allegheny Health Network and Illumina, Inc. announced a collaborative effort to assess their in-house comprehensive genomic testing to analyze the role of genetic tests in improving cancer care.
Brain Cancer Awareness Month: Advances in the Glioblastoma Landscape
May 18, 2022
Article
In an interview with Targeted Oncology, Stephen M. Karlovits, MD, discussed key developments that researchers have made in the primary brain tumor treatment landscape in recent years and upcoming trials with potential to improve outcomes for patients.
Krivak Breaks Down Data for First-Line Maintenance Therapy Options in Advanced Ovarian Cancer
April 27, 2022
Article
During a Targeted Oncology case-based roundtable event, Thomas C. Krivak, MD, discussed the results of studies of PARP inhibition for patients with advanced ovarian cancer.
Multiple Myeloma Awareness Month: Quadruplet Regimens Create New Outlook for Sequencing Therapy
March 31, 2022
Article
The evolving landscape for treating multiple myeloma has seen significant improvement for patients, giving them better options. One of the key regimens added to this landscape is the use of a new quadruplet regimen.
Highlights and Challenges in a Decade of New Multiple Myeloma Treatments
March 09, 2022
Video
Prerna Mewawalla, MD, looks back at a decade of advancements in the multiple myeloma space.
Cholangiocarcinoma Awareness Day: Bahary Reviews the Changing Landscape
February 12, 2022
Article
Nathan Bahary, MD, discussed with Targeted Oncology how the cholangiocarcinoma treatment paradigm has changed and what is on the horizon for treatment and care of patients.